Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail

Patients with coronary disease remain at high risk for future cardiovascular events, even with optimal risk factor modification, lipid-lowering drugs and antithrombotic regimens. A myriad of inflammatory pathways contribute to progression of the atherosclerotic burden in these patients. Only in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiolet, A. T. L., Opstal, T. S. J., Silvis, M. J. M., Cornel, J. H., Mosterd, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724334/
https://www.ncbi.nlm.nih.gov/pubmed/34403066
http://dx.doi.org/10.1007/s12471-021-01605-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724334/
https://www.ncbi.nlm.nih.gov/pubmed/34403066
http://dx.doi.org/10.1007/s12471-021-01605-3

Ejemplares similares